BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 28992824)

  • 1. A Nationwide Study of Pharmacists' Perception of the Impact of Medicare Part D on the Pharmacist-Patient Relationship.
    Spooner JJ; Spotts H; Khan S
    Consult Pharm; 2017 Oct; 32(10):629-644. PubMed ID: 28992824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare Part D: Pharmacists and formularies--whose job is it to address copays?
    Khan S
    Consult Pharm; 2014 Sep; 29(9):602-13. PubMed ID: 25203409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What can pharmacists' do about the Medicare Part D Donut hole and reimbursement? A six-state survey.
    Khan S
    Aging Clin Exp Res; 2015 Jun; 27(3):373-81. PubMed ID: 25373609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists.
    MacIntosh C; Weiser C; Wassimi A; Reddick J; Scovis N; Guy M; Boesen K
    J Am Pharm Assoc (2003); 2009; 49(1):26-30. PubMed ID: 19196593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
    Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
    Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community pharmacists' work environments: evidence from the 2004 National Pharmacist Workforce Study.
    Kreling DH; Doucette WR; Mott DA; Gaither CA; Pedersen CA; Schommer JC
    J Am Pharm Assoc (2003); 2006; 46(3):331-9. PubMed ID: 16739754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services.
    Famiyeh IM; MacKeigan L; Thompson A; Kuluski K; McCarthy LM
    Res Social Adm Pharm; 2019 May; 15(5):575-583. PubMed ID: 30100199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of pharmacist intention to provide Medicare medication therapy management services using the theory of planned behavior.
    Herbert KE; Urmie JM; Newland BA; Farris KB
    Res Social Adm Pharm; 2006 Sep; 2(3):299-314. PubMed ID: 17138516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perceptions of pharmacists and patients on information provision and their influence on patient satisfaction in Japanese community pharmacies.
    Takaki H; Abe T; Hagihara A
    J Eval Clin Pract; 2015 Dec; 21(6):1135-41. PubMed ID: 26268798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist and physician satisfaction and rates of switching to preferred medications associated with an instant prior authorization program for proton pump inhibitors in the North Carolina Medicaid program.
    Jacobson Vann JC; Christofferson S; Humble CG; Wegner SE; Feaganes JR; Trygstad TK
    J Manag Care Pharm; 2010 May; 16(4):250-63. PubMed ID: 20433216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of countries' pharmacist-patient communication legal requirements on prescription medications and alignment with practice: Comparison of Nordic countries.
    Svensberg K; Sporrong SK; Björnsdottir I
    Res Social Adm Pharm; 2015; 11(6):784-802. PubMed ID: 25698364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient satisfaction with a pharmacist-provided telephone medication therapy management program.
    Moczygemba LR; Barner JC; Brown CM; Lawson KA; Gabrillo ER; Godley P; Johnsrud M
    Res Social Adm Pharm; 2010 Jun; 6(2):143-54. PubMed ID: 20511113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing student pharmacist impact on patient over-the-counter medication selection.
    McConaha JL; Finoli LM; Heasley JE; Lunney PD
    J Pharm Pract; 2013 Jun; 26(3):280-7. PubMed ID: 23340915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacists' perceptions regarding the impact of hydrocodone rescheduling on prescription volume, workflow management, and patient outcomes.
    Varisco TJ; Ogunsanya ME; Barner JC; Fleming ML
    J Am Pharm Assoc (2003); 2017; 57(2S):S51-S62. PubMed ID: 28292504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional Variation in Pharmacist Perception of the Financial Impact of Medicare Part D.
    Khan S; Spooner JJ; Spotts HE
    Pharmacy (Basel); 2018 Jul; 6(3):. PubMed ID: 30018243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.